Latest H5N1 clinical trials Stories
Oxford University scientists have discovered a compound that greatly boosts the effect of vaccines against viruses like flu, HIV and herpes in mice.
Australian scientists looking to vaccinate chicken populations against a respiratory disease may have accidentally unleashed a disease far more deadly than the one they hoped to prevent.
Researchers at Baylor College of Medicine will receive up to $6.2 million over five years from the National Institute Of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a vaccine for severe acute respiratory syndrome, commonly called SARS.
While vaccines are perhaps medicine's most important success story, there is always room for improvement. Researchers at Oregon Health & Science University's Oregon National Primate Research Center (ONPRC) appear to have done just that.
- A volcanic mudflow.